CA2030346A1 - Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines - Google Patents
Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandinesInfo
- Publication number
- CA2030346A1 CA2030346A1 CA2030346A CA2030346A CA2030346A1 CA 2030346 A1 CA2030346 A1 CA 2030346A1 CA 2030346 A CA2030346 A CA 2030346A CA 2030346 A CA2030346 A CA 2030346A CA 2030346 A1 CA2030346 A1 CA 2030346A1
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- keto
- cardiac dysfunction
- prostaglandin compounds
- prostaglandin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000747 cardiac effect Effects 0.000 title abstract 2
- 230000004064 dysfunction Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP303840/1989 | 1989-11-22 | ||
JP30384089 | 1989-11-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2030346A1 true CA2030346A1 (fr) | 1991-05-23 |
CA2030346C CA2030346C (fr) | 2000-04-11 |
Family
ID=17925938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002030346A Expired - Fee Related CA2030346C (fr) | 1989-11-22 | 1990-11-20 | Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0430551B1 (fr) |
JP (1) | JPH0791191B2 (fr) |
KR (1) | KR0167557B1 (fr) |
AT (1) | ATE162717T1 (fr) |
CA (1) | CA2030346C (fr) |
DE (1) | DE69032000T2 (fr) |
DK (1) | DK0430551T3 (fr) |
ES (1) | ES2113345T3 (fr) |
GR (1) | GR3026105T3 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1206997C (zh) * | 1997-11-28 | 2005-06-22 | 株式会社·R-技术上野 | 内皮缩血管肽拮抗剂 |
ES2221859T3 (es) | 1999-10-15 | 2005-01-16 | Sucampo Ag | Composicion de compuestos biciclicos y procedimiento para su estabilizacion. |
US6414016B1 (en) * | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
TWI331920B (en) * | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
US7732487B2 (en) | 2001-11-19 | 2010-06-08 | Sucampo Ag | Method for treating a disease or condition responsive to opening of C1C-2 channel |
KR100804525B1 (ko) | 2005-03-24 | 2008-02-20 | 삼성에스디아이 주식회사 | 집적회로 칩용 방열부재 및 이를 구비한 디스플레이 모듈 |
WO2009104205A1 (fr) * | 2008-02-20 | 2009-08-27 | Lupin Limited | Formulation à libération retardée d’un activateur du canal chlorure |
CN102028696B (zh) * | 2009-09-24 | 2013-02-13 | 上海天伟生物制药有限公司 | 一种前列腺素类化合物的用途 |
US10457623B1 (en) | 2018-07-13 | 2019-10-29 | Chirogate International Inc. | Process for the preparation of Lubiprostone and intermediates thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2328132A1 (de) * | 1973-05-30 | 1975-01-02 | Schering Ag | Neue prostansaeurederivate und verfahren zu ihrer herstellung |
JPS581117B2 (ja) * | 1976-01-01 | 1983-01-10 | フアイザ−・インコ−ポレ−テツド | 11−デオキシ−ω−ペンタノルプロスタグランジン類 |
JPS5879973A (ja) * | 1981-11-09 | 1983-05-13 | Ono Pharmaceut Co Ltd | プロスタグランジン誘導体の重合体、その製造方法及び該重合体を有効成分として含有する治療剤 |
EP0153858A3 (fr) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | Application thérapeutique de prostaglandines |
JPS60208917A (ja) * | 1984-02-29 | 1985-10-21 | ジ・アツプジヨン・カンパニー | Ardsおよび多器官不全治療、予防におけるプロスタグランジンの使用 |
JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化 |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
JP2760514B2 (ja) * | 1988-07-20 | 1998-06-04 | 株式会社 上野製薬応用研究所 | 循環機能昂進剤 |
DE68906193T2 (de) * | 1988-05-23 | 1993-08-05 | Ueno Seiyaku Oyo Kenkyujo Kk | Hypersphyxia verursachende zusammensetzung. |
-
1990
- 1990-11-20 CA CA002030346A patent/CA2030346C/fr not_active Expired - Fee Related
- 1990-11-21 JP JP2319574A patent/JPH0791191B2/ja not_active Expired - Fee Related
- 1990-11-21 EP EP90312640A patent/EP0430551B1/fr not_active Expired - Lifetime
- 1990-11-21 DE DE69032000T patent/DE69032000T2/de not_active Expired - Fee Related
- 1990-11-21 ES ES90312640T patent/ES2113345T3/es not_active Expired - Lifetime
- 1990-11-21 DK DK90312640.7T patent/DK0430551T3/da active
- 1990-11-21 AT AT90312640T patent/ATE162717T1/de not_active IP Right Cessation
- 1990-11-22 KR KR1019900018960A patent/KR0167557B1/ko not_active IP Right Cessation
-
1998
- 1998-02-12 GR GR980400274T patent/GR3026105T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2113345T3 (es) | 1998-05-01 |
KR910009270A (ko) | 1991-06-28 |
JPH03218314A (ja) | 1991-09-25 |
JPH0791191B2 (ja) | 1995-10-04 |
DK0430551T3 (da) | 1998-04-14 |
ATE162717T1 (de) | 1998-02-15 |
KR0167557B1 (ko) | 1999-01-15 |
DE69032000D1 (de) | 1998-03-05 |
CA2030346C (fr) | 2000-04-11 |
DE69032000T2 (de) | 1998-05-14 |
EP0430551B1 (fr) | 1998-01-28 |
EP0430551A2 (fr) | 1991-06-05 |
EP0430551A3 (en) | 1992-07-15 |
GR3026105T3 (en) | 1998-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7404791A (en) | Treatment of cataract with 15-keto-prostaglandin compounds | |
CA2030345A1 (fr) | Utilisation d'un compose de 15-ceto-prostaglandines pour l'amelioration des fonctions encephaliques | |
CA2029596A1 (fr) | Medicaments contenant de l'acide lipoique r-a | |
EP0455448A3 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
ES2093774T3 (es) | Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. | |
EP0467564A3 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
CA2030346A1 (fr) | Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines | |
EP0424156A3 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
EP0430552A3 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
AU569354B2 (en) | (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane | |
AU639322B2 (en) | Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds | |
EP0469782A3 (en) | Treatment of cataract with prostacyclin compounds | |
AU591419B2 (en) | Medicament for curing arteriosclerosis comprising pyrimido (2,1-b) benzothiazole derivative | |
GR3029726T3 (en) | Use of a therapeutic compound for the treatment of bronchitis | |
AR245225A1 (es) | Composiciones para el tratamiento de cuero. | |
AU4246189A (en) | Medicament for the treatment of diseases caused by retroviruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |